OXANA ROMANOV: Open Payments
NPI 1063983526 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,936 in 54 payments from 12 companies in 2025. Trend: 2023 $2,446 · 2024 $1,950 · 2025 $1,936
Food & beverage: $1,754Education: $182
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $366 |
| ABBVIE INC. | 8 | $354 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $295 |
| Incyte Corporation | 10 | $231 |
| Organon LLC | 7 | $209 |
| LEO Pharma Inc. | 3 | $171 |
| GENZYME CORPORATION | 1 | $97 |
| Arcutis Biotherapeutics, Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
Products named: TREMFYA, SKYRIZI, OPZELURA, ANZUPGO, DUPIXENT, ILUMYA, VTAMA, Zoryve.
Industry payments across NY — which companies pay providers there.
